Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM)…
Search Posts
News Release
Report: Politics, Not Science, Drives Double Standard on Cannabis, Nicotine Policies
As the House votes on a bill this month to end the federal prohibition on cannabis – once unthinkable – a new Competitive…
Blog
Trump’s Drug Price Controls are a Lousy Deal for Patients
Prescription drug prices are popular targets for lawmakers—especially in an election year. Still, it came as quite a surprise when President Trump issued an…
The Washington Examiner
Government Alcohol Advice Should be Based on Evidence, Not Agendas
Should adults cut their alcohol consumption in half for health reasons? That’s what a federal government advisory committee is recommending. It matters because…
Blog
FDA Rules on E-cigarette Makers Go into Effect Today, to the Detriment of Public Health
The world was simpler in 2009 when Congress enacted a law that gave the Food and Drug Administration (FDA) the power to regulate tobacco.
Letters
CEI Joins Premarket Tobacco Authorization Coalition Letter
View Full Document as PDF Commissioner Hahn: On behalf of taxpayers and consumers across the country, the undersigned 15 organizations…
National Review
How Trump Can Help Reopen America’s Schools
It’s almost the middle of August, and many parents still have little idea if their kids will be able to go to school in a few…